
Photo Credit: March of Dimes
Scientific Frontline: Extended "At a Glance" Summary: Preventing Neonatal E. coli Sepsis
The Core Concept: Newborn babies who develop sepsis from E. coli bacteria suffer from a critical deficiency in specific maternally transferred antibodies that target a major surface protein common to all E. coli strains.
Key Distinction/Mechanism: While healthy babies are protected against bacterial pathogens via the natural transfer of bacteria-fighting antibodies from mothers during pregnancy, infants who develop neonatal sepsis exhibit a severe, more than 10-fold reduction in E. coli-specific antibodies. This lack of natural immunity is what allows the bacteria to rapidly spread through the blood and overwhelm the body.
Major Frameworks/Components:
- Neonatal Antibody Analysis: The study analyzed blood collected from 100 newborn babies diagnosed with E. coli sepsis to quantitatively measure specific antibody levels.
- Maternal-Fetal Immunity Transfer: Investigates the biological mechanisms of how protective immunoglobulins are naturally transferred from expectant mothers to fetuses.
- Probiotic Colonization Model: Experimental testing utilizing E. coli strain Nissle 1917 (commercially available as Mutaflor) to safely colonize the maternal intestinal tract and stimulate natural antibody production.

%20(resized).jpg)




.jpg)






.jpg)
.jpg)

.jpg)

